Boston Scientific Corporation (BVMF:B1SX34)

Market Cap	817.50B
Revenue (ttm)	103.12B
Net Income (ttm)	14.87B
Shares Out	n/a
EPS (ttm)	9.97
PE Ratio	54.96
Forward PE	31.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	93
Open	550.98
Previous Close	541.13
Day's Range	550.98 - 550.98
52-Week Range	498.56 - 615.11
Beta	0.67
RSI	59.71
Earnings Date	Feb 5, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: B1SX34

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD